China National Biotec Group, a subsidiary of China National Pharmaceutical Group Co Ltd (Sinopharm), announced on Friday that its biotech unit in Shanghai has received regulatory approval for clinical trials of China's first mRNA COVID-19 vaccine targeting the Omicron strains.
Sinopharm s mRNA Omicron vaccine gets green light for trials--China Economic Net en.ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.ce.cn Daily Mail and Mail on Sunday newspapers.